Biogen Inc (BIIB)
157.90
-0.11
(-0.07%)
USD |
NASDAQ |
Nov 22, 16:00
158.00
+0.10
(+0.06%)
After-Hours: 20:00
Biogen Cash from Investing (Quarterly): -1.181B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.181B |
| June 30, 2024 | 466.50M |
| March 31, 2024 | -66.00M |
| December 31, 2023 | -652.30M |
| September 30, 2023 | -1.742B |
| June 30, 2023 | -753.50M |
| March 31, 2023 | -953.00M |
| December 31, 2022 | -141.10M |
| September 30, 2022 | 1.672B |
| June 30, 2022 | 693.50M |
| March 31, 2022 | -648.00M |
| December 31, 2021 | -112.70M |
| September 30, 2021 | -233.60M |
| June 30, 2021 | -152.70M |
| March 31, 2021 | -64.70M |
| December 31, 2020 | -166.40M |
| September 30, 2020 | -52.40M |
| June 30, 2020 | -832.70M |
| March 31, 2020 | 442.90M |
| December 31, 2019 | 708.40M |
| September 30, 2019 | -365.90M |
| June 30, 2019 | -110.80M |
| March 31, 2019 | 238.80M |
| December 31, 2018 | -1.625B |
| September 30, 2018 | -619.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.148B |
| March 31, 2018 | 1.347B |
| December 31, 2017 | -769.50M |
| September 30, 2017 | -1.247B |
| June 30, 2017 | -202.50M |
| March 31, 2017 | -744.20M |
| December 31, 2016 | -581.70M |
| September 30, 2016 | 36.20M |
| June 30, 2016 | -736.10M |
| March 31, 2016 | -1.203B |
| December 31, 2015 | -1.808B |
| September 30, 2015 | -990.00M |
| June 30, 2015 | -1.253B |
| March 31, 2015 | -502.80M |
| December 31, 2014 | -378.30M |
| September 30, 2014 | -540.56M |
| June 30, 2014 | -630.13M |
| March 31, 2014 | 5.993M |
| December 31, 2013 | -710.01M |
| September 30, 2013 | -324.39M |
| June 30, 2013 | -726.24M |
| March 31, 2013 | 155.94M |
| December 31, 2012 | -375.45M |
| September 30, 2012 | -522.39M |
| June 30, 2012 | -53.12M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.742B
Minimum
Sep 2023
1.672B
Maximum
Sep 2022
-188.44M
Average
-146.90M
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Pfizer Inc | -2.057B |
| Sage Therapeutics Inc | 81.05M |
| Amgen Inc | -210.00M |
| Ionis Pharmaceuticals Inc | -340.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 935.60M |
| Cash from Financing (Quarterly) | -6.60M |
| Free Cash Flow | 1.768B |
| Free Cash Flow Per Share (Quarterly) | 5.514 |
| Free Cash Flow to Equity (Quarterly) | 803.70M |
| Free Cash Flow to Firm (Quarterly) | 847.12M |
| Free Cash Flow Yield | 7.67% |